22 Publications
2014
Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer.
Gökmen-Polar, YesimGokmen-Polar, YesimGoswami, Chirayu PGoswami, Chirayu PToroni, Rachel AToroni, Rachel ASanders, Kerry LSanders, Kerry LMehta, RutikaMehta, RutikaSirimalle, UshaSirimalle, UshaTanasa, BogdanTanasa, BogdanShen, ChangyuShen, ChangyuLi, LangLi, LangIvan, MirceaIvan, MirceaBadve, SunilBadve, SunilSledge, Jr, George W and Sledge, George W
Journal of Cancer, vol. 5, (no. 8), pp. 633-45, 2014. | Journal Article
2013
A gene signature to determine metastatic behavior in thymomas.
Gökmen-Polar, YesimGokmen-Polar, YesimCook, Robert WCook, Robert WGoswami, Chirayu PGoswami, Chirayu PankajWilkinson, JeffWilkinson, JeffMaetzold, DerekMaetzold, DerekStone, John FStone, John FOelschlager, Kristen MOelschlager, Kristen MVladislav, Ioan TudorVladislav, Ioan TShirar, Kristen LShirar, Kristen LKesler, Kenneth AKesler, Kenneth ALoehrer, Patrick JLoehrer, Sr, Patrick JBadve, Sunil and Badve, Sunil
PloS one, vol. 8, (no. 7), pp. e66047, 2013. | Journal Article
 
A Gene Signature to Determine Metastatic Behavior in Thymomas. e66047
Gökmen-Polar, YesimGokmen-Polar, YesimCook, Robert WGoswami, Chirayu PWilkinson, JeffMaetzold, DerekStone, John FOelschlager, Kristen MVladislav, Ioan TShirar, Kristen LKesler, KennethLoehrer, Patrick and Badve, Sunil
PLoS ONE, vol. 8, (no. 7), 2013. | Journal Article
 
FOXP3 expression and nodal metastasis of breast cancer.
Gökmen-Polar, YesimGokmen-Polar, YesimGökmen-Polar, YesimThorat, MangeshThorat, Mangesh AThorat, Mangesh A.Sojitra, PayalSojitra, PayalSojitra, PayalSaxena, RashmilSaxena, RashmilSaxena, RashmilBadve, SunilBadve, Sunil and Badve, Sunil
Cellular oncology (Dordrecht), vol. 36, (no. 5), pp. 405-9, 2013/Oct. | Journal Article
 
The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases.
Vladislav, I TudorVladislav, I TGokmen-Polar, YesimGökmen-Polar, YesimKesler, Kenneth AKesler, Kenneth ALoehrer, Patrick JLoehrer, Sr, Patrick JBadve, Sunil and Badve, Sunil
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol. 26, (no. 8), pp. 1059-64, 2013/Aug. | Journal Article
2012
Establishment and characterization of a novel cell line derived from human thymoma AB tumor.
Gökmen-Polar, YesimGokmen-Polar, YesimGökmen-Polar, YesimGökmen-polar, YesimSanders, Kerry LSanders, Kerry LSanders, Kerry LSanders, Kerry LGoswami, Chirayu PGoswami, Chirayu PGoswami, Chirayu PGoswami, Chirayu PCano, Oscar DCano, Oscar DCano, Oscar DCano, Oscar DZaheer, Narjis AZaheer, Narjis AZaheer, Narjis AZaheer, Narjis AJain, Rohit KJain, Rohit KJain, Rohit KJain, Rohit KKesler, Kenneth AKesler, Kenneth AKesler, Kenneth AKesler, Kenneth ANelson, Jr, Robert PNelson, Robert PNelson, Jr, Robert PNelson, Robert PVance, Gail HVance, Gail HVance, Gail HVance, Gail HSmith, DanielleSmith, DanielleSmith, DanielleSmith, DanielleLi, LangLi, LangLi, LangLi, LangCardoso, Angelo ACardoso, Angelo ACardoso, Angelo ACardoso, Angelo ABadve, SunilBadve, SunilBadve, SunilBadve, SunilLoehrer, Patrick JLoehrer, Patrick JLoehrer, Sr, Patrick JLoehrer, Sr, Patrick JSledge, Jr, George WSledge, George WSledge, Jr, George W and Sledge, George W
Laboratory investigation; a journal of technical methods and pathology, vol. 92, (no. 11), pp. 1564-73, 2012/Nov. | Journal Article
 
Extrathoracic metastases of thymic origin: a review of 35 cases.
Vladislav, TudorVladislav, TudorVladislav, TudorJain, Rohit KJain, Rohit KJain, Rohit KAlvarez, RudyAlvarez, RudyAlvarez, RudyMehta, Rutika JMehta, Rutika JMehta, Rutika JGokmen-Polar, YesimGökmen-polar, YesimGökmen-polar, YesimKesler, Kenneth AKesler, Kenneth AKesler, Kenneth AHenley, John DHenley, John DHenley, John DLoehrer Sr, Patrick JLoehrer Sr, Patrick JLoehrer, Patrick JBadve, SunilBadve, Sunil S and Badve, Sunil
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol. 25, (no. 3), pp. 370-7, 2012/Mar. | Journal Article
 
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models
Gokmen-Polar, YesimGökmen-Polar, YesimLiu, YiLiu, YiToroni, Rachel AToroni, Rachel ASanders, Kerry LSanders, Kerry LMehta, RutikaMehta, RutikaBadve, Sunil SBadve, SunilRommel, ChristianRommel, ChristianSledge, George W and Sledge, George W
Breast Cancer Research and Treatment, vol. 136, (no. 3), pp. 673-82, Dec 2012. | Journal Article
 
Molecular analysis of thymoma.
Badve, Sunil SGoswami, ChirayuGokmen-Polar, YesimNelson, Robert PHenley, JohnMiller, NickZaheer, Narjis ASledge, George WLi, LangKesler, Kenneth A and Loehrer, Patrick J
PloS one, vol. 7, (no. 8), pp. e42669, 2012. | Journal Article
2011
Biomarkers for breast cancer stem cells: the challenges ahead.
Gökmen-Polar, YesimGokmen-Polar, YesimNakshatri, HarikrishnaNakshatri, HarikrishnaBadve, Sunil and Badve, Sunil
Biomarkers in medicine, vol. 5, (no. 5), pp. 661-71, 2011/Oct. | Journal Article
 
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
Gökmen-Polar, Y.Gokmen-Polar, YesimGökmen-Polar, YesimToroni, Rachel A.Toroni, Rachel AHocevar, Barbara A.Hocevar, Barbara ABadve, SunilBadve, Sunil SZhao, QianqianZhao, QianqianShen, ChangyuShen, ChangyuBruckheimer, ElizabethBruckheimer, ElizabethKinch, Michael S.Kinch, Michael SMiller, Kathy D and Miller, Kathy D.
Breast Cancer Research and Treatment, vol. 127, (no. 2), pp. 375-84, Jun 2011. | Journal Article
 
Tumor marker assessment: points to ponder.
Gokmen-Polar, YesimGökmen-Polar, YesimBadve, Sunil and Badve, Sunil
Cancer biology & therapy, vol. 11, (no. 2), pp. 284-6, 2011/Jan/15. | Journal Article
2010
Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes
Gökmen-polar, YesimGokmen-Polar, YesimMehta, RutikaMehta, RutikaTuzmen, SukruTuzmen, SukruMousses, SpyroMousses, SpyroThorat, Mangesh AThorat, Mangesh ASanders, Kerry LSanders, Kerry LTurbin, DmitryTurbin, DmitryLeung, SamuelLeung, SamuelHuntsman, David GHuntsman, David GSledge, George WSledge, George WBadve, Sunil and Badve, Sunil S
Breast Cancer Research and Treatment, vol. 124, (no. 2), pp. 327-35, Nov 2010. | Journal Article
2008
Redefining the target again: chemotherapeutics as vascular disrupting agents?
Gokmen-Polar, YesimGokmen-Polar, YesimMiller, Kathy D and Miller, Kathy D
Cancer cell, vol. 14, (no. 3), pp. 195-6, 2008/Sep/9. | Journal Article
2007
2-methoxyestradiol inhibits the anaphase-promoting complex and protein translation in human breast cancer cells.
Bhati, RajendraGokmen-Polar, YesimSledge, George WFan, ChengNakshatri, HarikrishnaKetelsen, DavidBorchers, Christoph HDial, Michael JPatterson, Cam and Klauber-DeMore, Nancy
Cancer research, vol. 67, (no. 2), pp. 702-8, 2007/Jan/15. | Journal Article
 
A comparative proteomic study to characterize the vinblastine resistance in human ovarian cancer cells.
Brown, Dawn PGokmen-Polar, YesimJiang, LiTan, JianRingham, HeatherJanecki, Dariusz JQi, GuihongWitzmann, Frank ASledge, George W and Wang, Mu
Proteomics. Clinical applications, vol. 1, (no. 1), pp. 18-31, 2007/Jan. | Journal Article
2006
Protein kinase C-beta as a therapeutic target in breast cancer.
Sledge, George W and Gokmen-Polar, Yesim
Seminars in oncology, vol. 33, (no. 3 Suppl 9), pp. S15-8, 2006/Jun. | Journal Article
 
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model.
Shanmugam, RajasubramaniamJayaprakasan, VetrichelvanGokmen-Polar, YesimKelich, StephanieMiller, Kathy DYip-Schneider, MicheleCheng, LiangBhat-Nakshatri, PoornimaSledge, George WNakshatri, HarikrishnaZheng, Qi HuangMiller, Michael ADeGrado, TimothyHutchins, Gary D and Sweeney, Christopher J
The Prostate, vol. 66, (no. 14), pp. 1498-511, 2006/Oct/1. | Journal Article
2005
beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.
Gokmen-Polar, YesimEscuin, DanielWalls, Chad DSoule, Sharon EWang, YuefangSanders, Kerry LLavallee, Theresa MWang, MuGuenther, Brian DGiannakakou, Paraskevi and Sledge, George W
Cancer research, vol. 65, (no. 20), pp. 9406-14, 2005/Oct/15. | Journal Article
2004
Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo.
Murray, Nicole RJamieson, LeeYu, WangshengZhang, JieGökmen-Polar, YesimGokmen-Polar, YesimSier, DeborahAnastasiadis, PanosGatalica, ZoranThompson, E A and Fields, Alan P
The Journal of cell biology, vol. 164, (no. 6), pp. 797-802, 2004/Mar/15. | Journal Article
2003
EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
Lu, MingLu, MingMiller, KathyMiller, Kathy DGokmen-Polar, YesimGokmen-Polar, YesimJeng, Meei-HueyJeng, Meei-HueyKinch, Michael S and Kinch, Michael
Cancer research, vol. 63, (no. 12), pp. 3425-9, 2003/Jun/15. | Journal Article
2001
Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis.
Gokmen-Polar, YesimMurray, N RVelasco, M AGatalica, Z and Fields, A P
Cancer research, vol. 61, (no. 4), pp. 1375-81, 2001/Feb/15. | Journal Article